Health Tech | MedCity News
Yusuf Qasim, President of Payments Optimization at Zelis, discussed how the company is transforming healthcare payments from a fragmented, patchwork system into a modern, digital infrastructure.| MedCity News
August has seen a slew of executive hires, exits and layoffs across the healthcare sector. For example, OpenAI, Veradigm and Qure.ai welcomed new executives. There were also layoffs at organizations including BioNTech, CentraCare and Emory Healthcare. The post Healthcare Moves: A Monthly Summary of Hires, Exits and Layoffs appeared first on MedCity News.| MedCity News
Sleep.ai’s $5.5 million in funding was led by Treasure Coast Ventures and included participation from Nurture Ventures, the Harvard Business School Alumni Angels of Greater New York and Supermoon Capital. The post Sleep.ai Secures $5.5M to Scale Sleep Intelligence Platform appeared first on MedCity News.| MedCity News
In this episode, we’re joined by Abbie Clary, executive director of Health for All for CannonDesign, an architecture design company. She discusses why healthcare traditionally hasn’t been built around women, and what needs to change. The post MedCity FemFwd: Designing Healthcare Spaces for Women appeared first on MedCity News.| MedCity News
In a system already under incredible pressures, with more seemingly arriving every day, ROI becomes about not spending less but spending smarter. The post Does ROI Even Matter in Healthcare Anymore? appeared first on MedCity News.| MedCity News
When we give our hospitals the tools they deserve — predictive maintenance dashboards, smart alerts, clean analytics — we’re not just optimizing a process. We’re preserving trust. And lives. The post The Hidden Glitch in Healthcare: When Hospitals Still Run on Spreadsheets appeared first on MedCity News.| MedCity News
Cleveland Clinic is expanding its use of Dyania Health’s AI platform across the health system to speed up clinical trial recruitment. The system quickly scans patient records to identify eligible participants, aiming to give more patients access to trials and speed up development timelines for new therapies. The post Cleveland Clinic Taps Dyania Health to Speed Up Clinical Trials with AI appeared first on MedCity News.| MedCity News
A judge has approved Blue Cross Blue Shield’s $2.8 billion settlement with providers. However, some providers are opting out, arguing that it doesn’t go far enough. The post A Judge Approved BCBS’ $2.8B Settlement. Why Some Providers Are Opting Out appeared first on MedCity News.| MedCity News
Obesity and type 2 diabetes are among the cardiometabolic diseases included in Novo Nordisk’s R&D pact with Replicate Bioscience, a deal that could pay out up to $550 million. Startup Replicate specializes in therapies and vaccines based on self-replicating RNA. The post Novo Nordisk Turns to Self-Replicating RNA Startup to Discover New Metabolic Medicines appeared first on MedCity News.| MedCity News
For healthcare leaders, actionable SDOH insights are key to advancing equity and improving patient outcomes. By investing in comprehensive engagement strategies and leveraging technology, the healthcare industry can build trust, address barriers to care, and ensure that no patient falls through the cracks. The post Putting SDOH Data to Work for Systems and Patients appeared first on MedCity News.| MedCity News
[Sponsored] With carrier-added and noncarrier-added versions available, the right supplier can make the difference between a program that stalls and one that successfully reaches patients. The post The Top-Rated Suppliers of Lu-177 for Cancer Research appeared first on MedCity News.| MedCity News
Cybersecurity is no longer a function managed in the IT department’s back office. It’s a front-line brand issue, with real implications for patient satisfaction and loyalty. That means providers need to rethink how they talk about security. It’s no longer enough to be secure; you must communicate security clearly. The post Why Cybersecurity Is Now Central to the Patient Experience appeared first on MedCity News.| MedCity News
EVERSANA is merging with Waltz Health under the EVERSANA name. Mark Thierer, co-founder and CEO of Waltz Health, will serve as the CEO of the combined company. The post EVERSANA, Waltz Health Merge to Create $6B Prescription Drug Company appeared first on MedCity News.| MedCity News
Zemcelpro, a cord blood-sourced cell therapy developed by startup ExCellThera, received conditional marketing authorization in Europe as a treatment for blood cancer patients who can’t find a matched donor. It’s the first cell therapy approved in Europe for this group of patients. The post European Commission Approval Gives Blood Cancer Patients a New Cell Therapy Option appeared first on MedCity News.| MedCity News
Susan Monarez has been fired from her role as CDC director less than a month after her confirmation, following reported clashes with HHS Secretary Robert F. Kennedy Jr. over vaccine policy. This news comes amid a period of turmoil at the CDC, including a recent deadly shooting at its headquarters. The post CDC Director Ousted After Less Than a Month on the Job appeared first on MedCity News.| MedCity News
Moving clinical data management to cloud platforms can carry myriad benefits for healthcare organizations. The post Bringing Clinical Data Management to the Cloud appeared first on MedCity News.| MedCity News
The path to a sustainable HaH program looks different for regional systems. A smaller, more focused program, designed around their unique needs, can deliver strong clinical and operational value. The post How Can Hospital-at-Home Grow Outside the Nation’s Biggest Health Systems? appeared first on MedCity News.| MedCity News
[Sponsored] Using RWD to understand SDOH factors faced by patients with non-small cell lung cancer paves the way for improving health equity and more effective treatments for more people. The post The Role of RWD in Revolutionizing Clinical Trial Design appeared first on MedCity News.| MedCity News
Pluto Health launched an AI-driven digital hub that unifies fragmented health data, provides personalized care navigation and integrates clinical research opportunities to help close primary care access gaps. The platform aims to improve care coordination and make research participation more accessible, especially for patients without insurance or a regular primary care provider. The post Duke Spinout Launches Platform to Unite Care and Clinical Research appeared first on MedCity News.| MedCity News
Cemdisiran, a small interfering RNA drug that Regeneron Pharmaceuticals licensed from Alnylam Pharmaceuticals, met the goals of its pivotal test in generalized myasthenia gravis. The rare neuromuscular disease has several new therapies, but analysts see cemdisiran as having advantages over one particular class of drugs. The post Regeneron’s RNA Med for Muscle Disease Meets Trial Goals; FDA Filing Planned for Next Year appeared first on MedCity News.| MedCity News
Dreem Health introduced partnerships with Moona Health, DrLullaby and Daybreak. The partnerships aim to improve care for sleep conditions like insomnia and sleep apnea.| MedCity News
LB Pharmaceuticals’ planned IPO will fund late-stage clinical development of LB-102, a once-daily pill designed to improve on the old Sanofi schizophrenia drug Solian. The IPO filing follow a corporate restructuring in May that cut the jobs of LB’s chief financial and scientific officers to streamline operations and extend its cash runway. The post With a New Take on an Old Schizophrenia Drug, LB Pharma Prepares IPO to Fund Phase 3 Test appeared first on MedCity News.| MedCity News
Health care in the United States is confusing for patients and consumers. Price transparency is a step in the right direction — transformative change can happen by combining cost, quality, appropriateness and efficiency measures. The post Healthcare Price Transparency is Not Enough appeared first on MedCity News.| MedCity News
[Sponsored] Mobile IV therapy brings hydration and wellness straight to your door. Compare top providers, including Mountain Rocky IV Medics, and find the right fit for your health needs. The post On-Demand Relief: What IV Therapy Company Offers the Fastest Service? appeared first on MedCity News.| MedCity News
As operating environments become more complex, every element and system must be reliable, safe, and compliant with the web of regulations. Testing is the antidote to address these issues, however, this presents a significant testing burden. Here are some key challenges. The post Evaluating the Complexities of the Digital Operating Room appeared first on MedCity News.| MedCity News
The One Big Beautiful Bill Act introduced a new $50 billion fund to offer rural hospitals a financial lifeline. One expert cautions that this effort will fail to address systemic challenges without transparency, clear metrics and long-term infrastructure investment strategies. The post Without Clear Strategy, CMS’ $50B Rural Hospital Fund Risks Falling Short appeared first on MedCity News.| MedCity News
Overall customer satisfaction in Medicare Advantage plans is 623 points on a 1,000-point scale, a 29-point drop from last year, according to a new report from J.D. Power. The post Report: Member Satisfaction in MA Insurers Is Dropping Due to Lack of Trust appeared first on MedCity News.| MedCity News
Valneva must immediately cease U.S. shipments and sales of Ixchiq, a vaccine for chikungunya virus. The FDA recently lifted a pause on dosing of Ixchiq, but the agency’s new safety alert is based on an assessment that found the vaccine appears to be causing chikungunya-like illness in recipients. The post FDA Suspends Valneva Vaccine’s License Following New Reports of Adverse Events appeared first on MedCity News.| MedCity News
[Sponsored] The best assistive devices for children with sensory processing disorders are those that meet their needs. They will enhance their ability to participate more fully in daily activities. The post The Top-Rated Assistive Devices for Children With Sensory Processing Disorders appeared first on MedCity News.| MedCity News
If we truly believe in treating the whole patient, we must recognize that survival is not the only measure of success. Preserving a woman’s sense of self, her dignity, her identity, her autonomy is just as essential. The post Supporting the Whole Patient: The Psychological Value of Scalp Cooling in Breast Cancer Treatment appeared first on MedCity News.| MedCity News
Now, with the ability to measure coronary inflammation through AI-enhanced CT scans and to more accurately determine a person’s risk of heart attack, we can intervene earlier and more effectively. The post Regulatory Shift Paves Way for AI-Driven Heart Disease Diagnosis appeared first on MedCity News.| MedCity News
His longstanding anti-vaccine rhetoric and vocal opposition to science-backed expert consensus has caused widespread concern among public health and medical professionals about the appropriateness of his leadership.| MedCity News
Tools like remote monitoring and smart home integrations have not only increased convenience but also reduced the barriers that often prevent people from seeking or sticking with care, especially among older adults who overwhelmingly prefer to age in place.| MedCity News
As AI chatbots become a surrogate for human connection amid a national mental health crisis, experts are worried about these tools’ lack of safeguards — with research showing the models can provide dangerous, sometimes fatal, advice. Regulators and providers alike are scrambling to catch up with a technology that evolves faster than humans are able to understand.| MedCity News
Employers expect healthcare costs to rise by a median of 9% in 2026, according to a survey by the Business Group on Health. Pharmacy expenses are a key driver.| MedCity News
As manufacturers play an active role in the patients’ healthcare journey, the boundaries between manufacturers and healthcare providers/payers are becoming increasingly blurry.| MedCity News
In today’s healthcare landscape, your choice of medical billing partner directly impacts your bottom line. What are the best medical billing outsourcing companies, and which one is right for you?| MedCity News
Neurologists and health care practitioners must evolve with the world. Telemedicine carts assist in this evolution by serving as an intermediary between patients and doctors.| MedCity News
Small businesses are struggling with rising costs and tariffs, but many are still looking to maintain or increase health coverage, according to a recent report from Chase.| MedCity News
Novo Nordisk’s GLP-1 drug Wegovy expanded its label to include the metabolic disorder known as MASH. Analysts say there’s room for many MASH drugs with the treatment landscape expected to shape up to include combinations of therapies bringing different approaches to this fatty liver disease.| MedCity News
MedCity Influencers | MedCity News
Here are five guidelines to help employers balance health outcomes and financial responsibility to ensure that GLP-1 coverage is effective, affordable, and aligned with improved health and workforce well-being for employees and their families.| MedCity News
When transportation is integrated into the care continuum, everyone benefits: costs go down, appointments stay on track and beneficiaries receive the consistent care they deserve. This transformation isn’t just about speed; it’s about making every ride count.| MedCity News
Healthcare technology news, life science current events| MedCity News
Health Services | MedCity News
Johnathan (John) Welch is Chief Product Officer at Sphere, where he leads the Product organization and drives the roadmap for Sphere's payment and healthcare focused product suite. Originally from London, England, John is an internationally minded payments expert with over 15 years of experience working for some of the largest payment providers and banks in the world, including leadership roles at Wells Fargo, JPMorgan Chase, WorldPay, and MasterCard.| MedCity News
At a time when AI is reshaping pharma, Reverba Global CEO Cheryl Lubbert explained in an interview why empathy, context, and ethics still require a human touch.| MedCity News
Explore top-tier aesthetic certification programs that blend theory with hands-on training — perfect for health care pros ready to elevate their practice.| MedCity News
BioPharma, | MedCity News
Verona Pharma brings to Merck the inhaled drug Ohtuvayre, which is FDA approved as a treatment for chronic obstructive pulmonary disease. While Ohtuvayre is projected to become a blockbuster product in COPD alone, its potential extends to other respiratory disorders as well.| MedCity News
Health Tech | MedCity News
Healthcare is drowning in chaos—from scattered data to burnout-inducing tasks. Discover how smarter workflows and real-time insights can rescue care teams and transform patient outcomes.| MedCity News
Artificial Intelligence, | MedCity News
Rural hospitals are facing growing cybersecurity threats and digital demands but often lack the resources to respond — a gap Microsoft is working to close through discounted tools, free training and an AI innovation lab. The tech giant’s rural health initiative has reached more than 700 hospitals so far.| MedCity News
Healthcare staff are finding Artera’s AI agents helpful and easy to use after six months of real-world deployment. One of these copilots helps staff manage patient communications faster and more accurately, and the other gives providers access to data to better tailor their patient outreach efforts.| MedCity News
June has seen a slew of executive hires, promotions, exits and layoffs across the healthcare sector. For example, CVS Health and HCA Healthcare welcomed new executives, and Ascension and Optum Health announced that their CEOs are departing. There were also layoffs at organizations including Providence, UCSF Health and Vanderbilt University Medical Center.| MedCity News
The Supreme Court will soon hear oral arguments for a case that threatens coverage of preventive services without cost-sharing. Experts say this could make it significantly harder for patients to access care and lead to higher costs down the road.| MedCity News
The Supreme Court upheld the constitutionality of an Affordable Care Act provision requiring insurance coverage of certain preventive services without cost-sharing. Many healthcare leaders applauded the decision, though some concerns remain.| MedCity News
The home care industry is booming. As Baby Boomers age and more families seek in-home solutions for loved ones, demand for home care services is at an all-time high.| MedCity News
Many healthcare experts are calling Omada Health and Hinge Health's IPO debuts a success, though it's still early days.| MedCity News
Medical billing is a tedious administrative task, but outsourcing it may be the key to increased revenue. Explore the top medical billing outsourcing companies and the benefits of partnering with one.| MedCity News
Two digital health companies have gone public this year: Hinge Health and Omada Health. During a recent panel discussion, venture capitalists shared lessons learned about health tech in the public markets.| MedCity News
MedCity Influencers | MedCity News
BioPharma, | MedCity News
Pear Suite recently won the payer/provider technology track of MedCity News’ INVEST Pitch Perfect contest. The startup provides a software platform for community health workers that helps them share data, submit claims and maintain compliance.| MedCity News
The vast majority of healthcare data isn't used because it's difficult to work with, according to Beth Andrews, chief digital health officer of life sciences and healthcare at Dell Technologies. Andrews made these comments during a session at the MedCity News INVEST Digital Health conference.| MedCity News
Your varicose or spider veins may indicate an underlying problem, so finding the right vein specialist is crucial. Discover the best vein clinics in Orlando.| MedCity News
Discover Houston's best orthopedic surgery centers and what features — from personalized treatment plans to rehabilitation services — make these top providers stand out in their industry.| MedCity News
To ensure effective cost mitigation, employers can’t wait for the market to adjust — they have to punch first.| MedCity News
The health care sector is constantly operating, so patient miscommunication can occur at any time. Find out the top-rated companies that provide medical interpretation services.| MedCity News
By creating payment experiences that feel less like a burden and more like the seamless, convenient, flexible transactions patients experience elsewhere, we can significantly improve both patient satisfaction and financial performance.| MedCity News
As the FDA’s top biologics official, Peter Marks oversaw regulation of cell and gene therapies. The departure of Marks and mass layoffs throughout the FDA raise concerns about the agency’s ability to review and potentially approve such treatments.| MedCity News
The Trump administration recently cancelled billions of dollars in funding to the NIH. Healthcare experts say the funding cuts will delay the pace of medical research in the U.S. — which will not only hamper the commercialization of life-saving treatments, but could also hurt the country’s position as a global leader in healthcare and technology.| MedCity News
Patient expectations continue to evolve, and healthcare practices that fail to adapt risk more than just revenue—they risk losing trust.| MedCity News
Transitioning to PDPM models significantly shifted the healthcare industry. By replacing the RUG system, healthcare providers cut waste and more accurately reflect the care each patient received.| MedCity News
Despite their measurable clinical outcomes and contributions to patient well-being, they often face a dismissive perception as mere providers of ice bags and stretch bands. However, an economic crisis is threatening this vital profession, and the blame extends beyond insurance payors.| MedCity News
The latest news covering use of artificial intelligence in the healthcare industry| MedCity News
When it comes to managing inbound phone calls, underperformance has devastating cost implications.| MedCity News
Illumina originally spun off Grail in early 2017. Grail plans to launch its test for early detection of cancers, Galleri, next year. Illumina already owns 14.5% of the company, which it started in 2016.| MedCity News
In closing its Grail acquisition before U.S. and European regulators sign off, Illumina is taking a chance the deal will pass regulatory muster. It’s a potentially pricey gambit, as Illumina could face fines for its early action and there are no assurances that regulators will agree that the deal is not anticompetitive.| MedCity News
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.| MedCity News
Health Tech, | MedCity News
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.| MedCity News
Closing cancer health equity gaps require medical breakthroughs made possible by new funding approaches.| MedCity News
Sponsored Post, | MedCity News
Executives from Imagine360, Verily, BrightInsight, Lantern, and Rhapsody shared their approaches to reducing healthcare costs and facilitating digital transformation.| MedCity News
Stephanie Baum is the Director of Special Projects for MedCityNews. She graduated from Franklin & Marshall College in Pennsylvania and has worked across radio, print and video. She's worked for Dow Jones & Co., The Legal Intelligencer, The Christian Science Monitor, AP Radio's London bureau, and United Business Media. LinkedIn: https://www.linkedin.com/in/stephanie-baum-24a7406/| MedCity News
Illumina has decided against further appeals of U.S. and European antitrust litigation challenging its acquisition of liquid biopsy company Grail. Illumina expects to have terms of the divestiture set by the end of the second quarter of 2024.| MedCity News
Illumina must pay a €432 million fine for closing its Grail acquisition before the European Commission finished its inquiry into the tie-up. The penalty is the maximum amount the regulator can impose on a company for breaching European merger rules.| MedCity News
The Federal Trade Commission is opposing Illumina’s proposed $7.1 billion Grail acquisition, arguing that it will reduce competition for multi-cancer early detection tests. Illumina disagrees with the regulator’s position and will oppose the FTC’s challenge.| MedCity News
These strategies and practices can significantly shorten the life cycle of claims, leading to quicker resolutions and improved financial outcomes.| MedCity News
MedCity Influencers | MedCity News
As Gen AI continues to mature, there will be ways to employ these technologies thoughtfully and safely in healthcare today. The key is to continue to embrace new breakthroughs – with strong guardrails for safety, privacy and transparency.| MedCity News
We must empower health plan members with culturally and linguistically-relevant information about their benefits and health – tools that in turn encourage them to adopt a proactive and informed approach to their well-being.| MedCity News
Many healthcare providers saw their revenues and operating margins grow in July, despite the fact that both labor and non-labor expenses continue to grow, according to new data.| MedCity News
As RNA biology and RNA therapeutics emerge in the mainstream of pharma, RNA foundation models offer massive potential for revolutionizing R&D.| MedCity News
A federal judge recently blocked the FTC's ban on noncompetes. The decision has important implications for healthcare.| MedCity News
Here is a selection of recent executive hires, retirements, promotions and layoffs occurring across the healthcare industry.| MedCity News
Check out news from Oral Genome, BeMe Health, Noetik, and Vouched.| MedCity News
